PTGS2 and neoplasm: They concluded that the tumor regression activity is associated with reduced activity of cyclin D1, nonhistone nuclear protein (Ki-67), cyclooxygenase-2 (COX-2), survivin, NF-κB, and increased activity of caspase-3 function.